What is CVE-2018-18564?

CVE-2018-18564 is a high-severity vulnerability in Roche Accu-Chek Inform Ii. CVSS score: 7.4/10. Published 2018-11-20.

How severe is CVE-2018-18564?

High severity. CVSS v3 base score is 7.4 out of 10.

Vulnerability in Roche Accu-Chek Inform Ii

CVE-2018-18564

An issue was discovered in Roche Accu-Chek Inform II Instrument before 03.06.00 (Serial number below 14000) and 04.x before 04.03.00 (Serial Number above 14000), CoaguChek Pro II before 04.03.00, and cobas h 232 before 04.00.04 (Serial number above KQ0400000 or KS0400000). Improper access control allows attackers in the adjacent network to change the instrument configuration.

EPSS: 0.006 (44.5th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 7.4 (High). Vector: CVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:C/C:N/I:H/A:N.

Affected products

References

cve@mitre.org (US Government Resource, Third Party Advisory, x_refsource_MISC, Mitigation)
cve@mitre.org (VDB Entry, Third Party Advisory, vdb-entry, x_refsource_BID)

Frequently asked questions

What is CVE-2018-18564?: CVE-2018-18564 is a high-severity vulnerability in Roche Accu-Chek Inform Ii. CVSS score: 7.4/10. Published 2018-11-20.
How severe is CVE-2018-18564?: High severity. CVSS v3 base score is 7.4 out of 10.